Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1-Erratum.

Scott, Jeffrey R; Courter, Joshua D; Saldaña, Shannon N; Widemann, Brigitte C; Fisher, Michael; Weiss, Brian; Perentesis, John; Vinks, Alexander A

Scott, Jeffrey R; Courter, Joshua D; Saldaña, Shannon N; Widemann, Brigitte C; Fisher, Michael; Weiss, Brian; Perentesis, John; Vinks, Alexander A.

Afiliación

Scott JR; 1Division of Pharmacy, Cincinnati Children's Hospital Medical Center 2Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center 3Department of Pediatrics, University of Cincinnati, College of Medicine 4Cancer & Blood Disease Institute, Division of Oncology, Cincinnati Children's Hospital Medical Center 5Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 6Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.

Ther Drug Monit ; 38(2): 284, 2016 04.

Article en En | MEDLINE | ID: mdl-26829601

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Ther Drug Monit Año: 2016 Tipo del documento: Article País de afiliación: Panamá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google